Author:
Michelotti Andrea,Venturini Marco,Tibaldi Carmelo,Bengala Carmelo,Gallo Luigi,Carnino Flavio,Mastro Lucia Del,Lionetto Rita,Montanaro Elda,Rosso Riccardo,Conte Pierfranco
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Launchbury AP, Habboubi N: Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity. Cancer Treat Rev 19: 197–228, 1993
2. Perez DJ, Harvey VJ, Robinson BA, Atkinson CH, Dady PJ, Kirk AR et al: A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer. J Clin Oncol 9: 2148–2152, 1991
3. Bonadonna G, Gianni L, Santoro A, Bonfante V, Bidoli P, Casali P et al: Drugs ten years later: epirubicin. Ann Oncol 4: 359–369, 1993
4. Carmo-Pereira J, Costa FO, Miles DW, Henriques E, Richards MA, Rubens RO et al: High dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study. Cancer Chemother Pharmacol 27: 394–396, 1991
5. Hickish T, Cunningham D, Haydock A, Coombes RC: Experience with intermediate dose (110- 120mg/m2) epirubicin. Cancer Chemother Rep 24: 61–64, 1989
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献